IRONWOOD PHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
  • Ironwood Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $3.65M, a 76.2% decline year-over-year.
  • Ironwood Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$2.46M, a 99.7% increase year-over-year.
  • Ironwood Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$1B, a 672% decline from 2022.
  • Ironwood Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was $175M, a 66.9% decline from 2021.
  • Ironwood Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was $528M, a 398% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1B -$1.18B -672% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-16
2022 $175M -$353M -66.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-16
2021 $528M +$422M +398% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 $106M +$84.7M +394% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $21.5M +$304M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 -$282M -$165M -141% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-17
2017 -$117M -$35.2M -43.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 -$81.7M +$61M +42.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 -$143M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.